These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 24076374

  • 1. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway.
    Zhang H, Tan S, Wang J, Chen S, Quan J, Xian J, Zhang Ss, He J, Zhang L.
    Exp Cell Res; 2014 Jan 01; 320(1):119-27. PubMed ID: 24076374
    [Abstract] [Full Text] [Related]

  • 2. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
    Han Y, Ye A, Zhang Y, Cai Z, Wang W, Sun L, Jiang S, Wu J, Yu K, Zhang S.
    PLoS One; 2015 Jan 01; 10(8):e0136484. PubMed ID: 26308531
    [Abstract] [Full Text] [Related]

  • 3. Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.
    Duggimpudi S, Kloetgen A, Maney SK, Münch PC, Hezaveh K, Shaykhalishahi H, Hoyer W, McHardy AC, Lang PA, Borkhardt A, Hoell JI.
    J Biol Chem; 2018 Oct 05; 293(40):15359-15369. PubMed ID: 30126842
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS, Liu DS, Dai CW, Li RJ.
    Am J Hematol; 2006 Apr 05; 81(4):242-55. PubMed ID: 16550520
    [Abstract] [Full Text] [Related]

  • 5. Betuletol 3-methyl ether induces G(2)-M phase arrest and activates the sphingomyelin and MAPK pathways in human leukemia cells.
    Rubio S, Quintana J, Eiroa JL, Triana J, Estévez F.
    Mol Carcinog; 2010 Jan 05; 49(1):32-43. PubMed ID: 19676104
    [Abstract] [Full Text] [Related]

  • 6. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
    Ding SZ, Smith MF, Goldberg JB.
    J Gastroenterol Hepatol; 2008 Jul 05; 23(7 Pt 2):e67-78. PubMed ID: 18702686
    [Abstract] [Full Text] [Related]

  • 7. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 8. Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt.
    Moon DO, Park SY, Heo MS, Kim KC, Park C, Ko WS, Choi YH, Kim GY.
    Int Immunopharmacol; 2006 Dec 05; 6(12):1796-807. PubMed ID: 17052670
    [Abstract] [Full Text] [Related]

  • 9. Dynamic transcriptomes of human myeloid leukemia cells.
    Wang H, Hu H, Zhang Q, Yang Y, Li Y, Hu Y, Ruan X, Yang Y, Zhang Z, Shu C, Yan J, Wakeland EK, Li Q, Hu S, Fang X.
    Genomics; 2013 Oct 05; 102(4):250-6. PubMed ID: 23806289
    [Abstract] [Full Text] [Related]

  • 10. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells.
    Kohmura K, Miyakawa Y, Kawai Y, Ikeda Y, Kizaki M.
    J Cell Physiol; 2004 Mar 05; 198(3):370-6. PubMed ID: 14755542
    [Abstract] [Full Text] [Related]

  • 11. Paris saponin VII induces cell cycle arrest and apoptosis by regulating Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells.
    Yan T, Hu G, Wang A, Sun X, Yu X, Jia J.
    Phytother Res; 2018 May 05; 32(5):898-907. PubMed ID: 29377384
    [Abstract] [Full Text] [Related]

  • 12. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells.
    Matsumoto E, Hatanaka M, Bohgaki M, Maeda S.
    Kobe J Med Sci; 2006 May 05; 52(6):181-94. PubMed ID: 17329956
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
    Thol F, Winschel C, Sonntag AK, Damm F, Wagner K, Chaturvedi A, Göhring G, Schlegelberger B, Lübbert M, Fiedler W, Kirchner H, Krauter J, Ganser A, Heuser M.
    Ann Hematol; 2013 Mar 05; 92(3):315-23. PubMed ID: 23233047
    [Abstract] [Full Text] [Related]

  • 14. Musashi 2 in hematopoiesis.
    de Andrés-Aguayo L, Varas F, Graf T.
    Curr Opin Hematol; 2012 Jul 05; 19(4):268-72. PubMed ID: 22517588
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
    Nimmanapalli R, O'Bryan E, Huang M, Bali P, Burnette PK, Loughran T, Tepperberg J, Jove R, Bhalla K.
    Cancer Res; 2002 Oct 15; 62(20):5761-9. PubMed ID: 12384536
    [Abstract] [Full Text] [Related]

  • 16. Anti-leukemic effect of 2-pyrone derivatives via MAPK and PI3 kinase pathways.
    Yoon JS, Won YW, Kim SJ, Oh SJ, Kim ES, Kim BK, Cho CG, Choi JH, Park BB, Lee MH, Lee YY.
    Invest New Drugs; 2012 Dec 15; 30(6):2284-93. PubMed ID: 22526834
    [Abstract] [Full Text] [Related]

  • 17. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J, Zhao Y, Kauss MA, Spindel S, Lian H.
    Eur J Cell Biol; 2009 Feb 15; 88(2):103-15. PubMed ID: 19058874
    [Abstract] [Full Text] [Related]

  • 18. [Effect of WT1 antisense oligonucleotide on proliferation and apoptosis of human leukemia cells].
    Wu X, Wang Y, Pei X.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Dec 15; 20(12):631-3. PubMed ID: 11721364
    [Abstract] [Full Text] [Related]

  • 19. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade.
    Mandal C, Dutta A, Mallick A, Chandra S, Misra L, Sangwan RS, Mandal C.
    Apoptosis; 2008 Dec 15; 13(12):1450-64. PubMed ID: 18987975
    [Abstract] [Full Text] [Related]

  • 20. Bcl-xL is a dominant antiapoptotic protein that inhibits homoharringtonine-induced apoptosis in leukemia cells.
    Yin S, Wang R, Zhou F, Zhang H, Jing Y.
    Mol Pharmacol; 2011 Jun 15; 79(6):1072-83. PubMed ID: 21415308
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.